PACT PHARMA Trademark

Trademark Overview

On Saturday, November 9, 2019, a trademark application was filed for PACT PHARMA with the United States Patent and Trademark Office. The USPTO has given the PACT PHARMA trademark a serial number of 88686147. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Tuesday, November 14, 2023. This trademark is owned by PACT Pharma, Inc.. The PACT PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
pact pharma

General Information

Serial Number88686147
Word MarkPACT PHARMA
Filing DateSaturday, November 9, 2019
Status711 - CANCELLED - SECTION 7
Status DateTuesday, November 14, 2023
Registration Number6503027
Registration DateTuesday, September 28, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 1, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
Disclaimer with Predetermined Text"PHARMA"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateTuesday, November 14, 2023
Primary Code005
First Use Anywhere DateMonday, November 25, 2019
First Use In Commerce DateMonday, November 25, 2019

Trademark Owner History

Party NamePACT Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePACT Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NamePACT Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Wednesday, November 15, 2023NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Tuesday, November 14, 2023CANCELLED SECTION 7-TOTAL
Friday, June 16, 2023REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Tuesday, November 7, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 7, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 16, 2023TEAS SECTION 7 SURRENDER RECEIVED
Tuesday, September 28, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, August 24, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 23, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 23, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, August 18, 2021USE AMENDMENT FILED
Monday, August 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 18, 2021TEAS STATEMENT OF USE RECEIVED
Tuesday, July 27, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 1, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 1, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 12, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, April 24, 2021EXAMINER'S AMENDMENT ENTERED
Saturday, April 24, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, April 24, 2021EXAMINERS AMENDMENT E-MAILED
Saturday, April 24, 2021EXAMINERS AMENDMENT -WRITTEN
Thursday, April 22, 2021JURISDICTION RESTORED TO EXAMINING ATTORNEY
Tuesday, December 8, 2020REPLY BRIEF FILED - CHECK TTAB FILES
Monday, November 16, 2020NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
Monday, November 16, 2020EXAMINERS STATEMENT E-MAILED
Monday, November 16, 2020EXAMINERS STATEMENT - COMPLETED
Monday, September 28, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, August 31, 2020NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Monday, August 31, 2020ACTION DENYING REQ FOR RECON E-MAILED
Monday, August 31, 2020ACTION CONTINUING FINAL - COMPLETED
Saturday, August 29, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, August 29, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 27, 2020ASSIGNED TO LIE
Friday, August 7, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Friday, August 7, 2020EX PARTE APPEAL-INSTITUTED
Friday, August 7, 2020JURISDICTION RESTORED TO EXAMINING ATTORNEY
Friday, August 7, 2020EXPARTE APPEAL RECEIVED AT TTAB
Saturday, July 18, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, July 18, 2020FINAL REFUSAL E-MAILED
Saturday, July 18, 2020FINAL REFUSAL WRITTEN
Tuesday, July 7, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 7, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION E-MAILED
Thursday, February 20, 2020NON-FINAL ACTION WRITTEN
Thursday, February 13, 2020ASSIGNED TO EXAMINER
Saturday, November 16, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 13, 2019NEW APPLICATION ENTERED

Related Keywords

pharma pact cancer treatment preparations pharmaceutical oncological namely management products conditions biological